Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Ana Gudelj-Gračanin"'
Autor:
Majda Golob, Ivan Marković, Neno Zovko, Davorin Šakić, Ana Gudelj-Gračanin, Jadranka Morović-Vergles
Publikováno v:
Acta Clinica Croatica, Vol 57., Iss 1., Pp 16-21 (2018)
The aim of the study was to determine the prevalence of neuropathic pain in knee osteoarthritis patients using painDETECT questionnaire, and to evaluate correlations between pain intensity, gender, age and types of treatment, and the presence of neur
Externí odkaz:
https://doaj.org/article/0a548784f39c47efa711f533e32c2972
Autor:
Marija Jelušić, Rolando Cimaz, Merav Heshin, Domagoj Kifer, Nastasia Kifer, Neil A. Martin, Angelo Ravelli, Saša Sršen, Martina Held, Alenka Gagro, Ana Gudelj Gračanin, Mario Sestan, Marijana Ćorić, Seza Ozen, Teresa Giani, Stela Bulimbasic
Publikováno v:
Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::32be38aacd10bf18e655538f43f9d500
https://doi.org/10.1136/archdischild-2021-europaediatrics.443
https://doi.org/10.1136/archdischild-2021-europaediatrics.443
Autor:
Marija Jelušić, Ana Gudelj Gračanin, Matej Šapina, Aleksandar Ovuka, Marijana Ćorić, Ana Kozmar, Nastasia Kifer, Alenka Gagro, Mateja Batnozic Varga, Stela Bulimbašić, Saša Sršen, Martina Held, Mario Sestan, Marijan Frković, Gordana Laškarin
Publikováno v:
Therapeutic Advances in Musculoskeletal Disease
Therapeutic Advances in Musculoskeletal Disease, Vol 13 (2021)
Therapeutic Advances in Musculoskeletal Disease, Vol 13 (2021)
Background:We analysed clinical and biochemical parameters in predicting severe gastrointestinal (GI) manifestations in childhood IgA vasculitis (IgAV) and the risk of developing renal complications.Methods:A national multicentric retrospective study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f65190dcc39a0756a327f8e27759bb87
https://doi.org/10.1177/1759720x211024828
https://doi.org/10.1177/1759720x211024828
Autor:
Ana, Gudelj Gračanin, Aldenita, Matić, Tea, Mikula, Jasminka, Dobša, Iva, Žagar, Lana, Mužinić Marinić, Jadranka, Morović-Vergles
Publikováno v:
Psychiatria Danubina. 32(Suppl 4)
Rheumatoid arthritis (RA) is a chronic and disabling disease with a great impact on the quality of life (QOL). The aim of this study was to assess QOL and health in RA patients treated with biological disease-modifying drugs (bDMARDs) as opposed to t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4e91d011acb328bbe3398a04b7cadd1e
https://pubmed.ncbi.nlm.nih.gov/33212462
https://pubmed.ncbi.nlm.nih.gov/33212462
IgA-vaskulitis sa zahvaćanjem bubrega u odrasloj dobi: iskustva iz Kliničke bolnice Dubrava, Za greb
Autor:
Jasminka Dobša, Matej Nedić, Gabrijela Buljan, Karla Draženović, Ivica Horvatić, Krešimir Galešić, Matea Liskij, Danica Galešić Ljubanović, Majda Golob, Ana Gudelj Gračanin, Luka Toric, Tea Mikula
Publikováno v:
Reumatizam
Volume 67
Issue 2
Volume 67
Issue 2
Introduction: IgA vasculitis, formerly named Henoch-Schönlein purpura, is a systemic small-vessel vasculitis that occurs commonly in children, while in adults, the disease remains rare. It is characterised by non-thrombocytopenic palpable purpura, a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c0068e62906b18eb6fe940a7df825c1
https://hrcak.srce.hr/file/381321
https://hrcak.srce.hr/file/381321
Autor:
Marko Lucijanic, Ivan Marković, Ana Marija Valetić, Ana Gudelj Gračanin, Jadranka Morović-Vergles, Majda Golob
Publikováno v:
Acta Clinica Croatica, Vol 59, Iss 2., Pp 312-316 (2020)
Acta clinica Croatica
Volume 59.
Issue 2.
Acta Clinica Croatica
Acta clinica Croatica
Volume 59.
Issue 2.
Acta Clinica Croatica
The aim of this study was to investigate the association of smoking with disease activity, seropositivity, age and gender in patients with rheumatoid arthritis. We included 89 rheumatoid arthritis patients. All patients fulfilled the 2010 American Co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5b1b24bd0c8bceaa707a8d6aeda35b9
https://www.bib.irb.hr/1252134
https://www.bib.irb.hr/1252134
Autor:
Petra Simac, Željka Kolak, Simeon Grazio, Marija Glasnović, Jadranka Morović-Vergles, Iva Žagar, Nadica Laktašić Žerjavić, Frane Grubišić, Dijana Perković, Helena Kolar Mitrović, Ines Doko, Ana Gudelj Gračanin, Porin Perić
Publikováno v:
Abstracts Accepted for Publication.
Background: In rheumatoid arthritis (RA) and psoriatic arthritis (PsA) methotrexate (MTX) is usually the first choice in the treatment strategy. Bioavailability of oral MTX reaches plateau in doses ≥15 mg weekly, and this is the reason of its lower
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d8c984e6ad24e9d7ee3afbab7ed21ffb
https://doi.org/10.1136/annrheumdis-2019-eular.4961
https://doi.org/10.1136/annrheumdis-2019-eular.4961
Autor:
Sven Seiwerth, Petra Turčić, Željko Kaštelan, Piotr Wardega, Jelena Barać Žutelija, Mario Gabričević, Nikola Štambuk, Hrvoje Šošić, Renata Novak Kujundžić, Damir Babić, Ana Gudelj Gračanin, Gorana Aralica, Paško Konjevoda
Publikováno v:
International Journal of Molecular Sciences
Volume 20
Issue 9
International Journal of Molecular Sciences, Vol 20, Iss 9, p 2090 (2019)
Volume 20
Issue 9
International Journal of Molecular Sciences, Vol 20, Iss 9, p 2090 (2019)
The purpose of this paper was to outline the development of short peptide targeting of the human prostate specific antigen (hPSA), and to evaluate its effectiveness in staining PSA in human prostate cancer tissue. The targeting of the hPSA antigen by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e9e5cd6f4bd651480be0dec8edf6eb0
Publikováno v:
Reumatizam. 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a4b4bdd03e7f212fd9407b70f5a127e8
https://doi.org/10.33004/reumatizam-66-1-1
https://doi.org/10.33004/reumatizam-66-1-1
Publikováno v:
Reumatizam
Volume 66
Issue 1 (online first)
Volume 66
Issue 1 (online first)
Pri neučinkovitosti sintetskih lijekova koji modificiraju tijek bolesti (engl. disease-modifying antirheumatic drugs – DMARD s; u tekstu DMARD -i) u liječenju bolesnika s aktivnim reumatoidnim artritisom (RA ) možemo primijeniti jedan od biološ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______951::f71889ba9b26d360c54dafc0f5e4dd7a
https://hrcak.srce.hr/file/329609
https://hrcak.srce.hr/file/329609